Efficacy of Short-Term Cyclosporine Treatment to Control Psoriasis-Related Events during Efalizumab Therapy

Antonio Costanzo,Marina Talamonti,Giulia Spallone,Elisabetta Botti,Maria Sole Chimenti,Marina Papoutsaki,Sergio Chimenti

Efficacy of Short-Term Cyclosporine Treatment to Control Psoriasis-Related Events during Efalizumab Therapy

2009

Antonio Costanzo
Marina Talamonti
Giulia Spallone
Elisabetta Botti
Maria Sole Chimenti
Marina Papoutsaki
Sergio Chimenti

Efalizumab is a recombinant humanized anti-CD11a monoclonal antibody that blocks the activation, adhesion and trafficking of T cells and has been approved for the treatment of moderate-to-severe plaqu

Keywords:

Psoriasis
Dermatology
Pharmacology
Combination therapy
Immunology
Efalizumab
Medicine
Adverse effect
Monoclonal antibody
Recombinant DNA

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations